Preparation of novel aminopyridines having Aurora A selective inhibitory action.

  • Ohkubo M
  • Kato T
  • Kawanishi N
  • et al.
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.

Abstract

The title compds. I [R1, R2 = H, lower alkyl, or alternatively R1 and R2 are combined together to form CH2; R3 = halo; R4 = halo or Me substituted with 1-3 halogen atoms; X = CH, N; W = (un)substituted thiazolyl, pyrazolyl, thiadiazolyl; with the proviso] which are Aurora A selective inhibitors useful in combination therapy of cancer, were prepd. E.g., a multi-step synthesis of I [R1, R2 = H; R3 = F; R4 = Cl; X = CH; W = 2-thiazolyl], starting from (6-bromopyridin-2-yl)methanol, was given (no characterization data provided for intermediates). The compds. I exhibit excellent Aurora A selective activity (biol. data were provided for exemplified compds. I). Pharmaceutical compns. comprising the compd. I alone or in combination with other antitumor agent(s) were disclosed. [on SciFinder(R)]

Cite

CITATION STYLE

APA

Ohkubo, M., Kato, T., Kawanishi, N., Mita, T., & Shimomura, Toshiyasu. (2006, May 4). Preparation of novel aminopyridines having Aurora A selective inhibitory action. PCT Int. Appl. Banyu Pharmaceutical Co., Ltd., Japan .

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free